National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, UK.
Otology and Hearing Group, Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, UK.
J Clin Psychol. 2019 Jul;75(7):1203-1218. doi: 10.1002/jclp.22771. Epub 2019 Mar 11.
To scope the literature describing misophonia populations, management, and research opportunities.
Literature searches for research studies describing patients diagnosed with misophonia, defining a patient profile, or outlining development or testing of an intervention for misophonia. A data extraction form was developed and piloted before data from each article were independently charted by two researchers. Researchers then agreed on a final data set for each article.
Thirty-one records were included. The misophonia population was described in terms of onset age, triggers, reaction, coping strategies, and comorbid conditions. We identified nine outcome measures. Case studies on treatments included cognitive behavioral therapy, counterconditioning, mindfulness and acceptance, dialectical behavioral therapy, and pharmaceuticals. Future research priorities identified included clarifying the phenomenology and prevalence of misophonia, and randomized controlled trials of treatments.
Misophonia is under-researched but there are strong foundations for future research to finalize diagnostic criteria, validate outcome measures, and trial treatments.
综述描述恐声症患者人群、管理和研究机会的文献。
对描述患有恐声症的患者、定义患者特征、或概述针对恐声症的干预措施的开发或测试的研究进行文献检索。在对每条文章的数据进行独立记录之前,先制定并试用数据提取表格,然后由两名研究人员对表格中的数据进行记录。最后,研究人员针对每篇文章达成了最终的数据集合。
共纳入 31 项记录。从发病年龄、诱因、反应、应对策略和合并症等方面对恐声症患者人群进行了描述。我们确定了九项结果评估指标。针对治疗的个案研究包括认知行为疗法、条件反射疗法、正念与接纳、辩证行为疗法和药物治疗。确定的未来研究重点包括明确恐声症的现象学和流行率,以及针对治疗方法的随机对照试验。
恐声症的研究还不够充分,但为进一步确定诊断标准、验证结果评估指标以及试验治疗方法奠定了坚实的基础。